Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05956886 · ClinicalTrials.gov registry record · NA
Sleep Chatbot Intervention for Emerging Black/African American Adults
A NA study of Insomnia and Metabolic Syndrome, sponsored by University of Delaware.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05956886: Completed NA study of Insomnia and Metabolic Syndrome, sponsored by University of Delaware.
NCT05956886 is a NA study of Insomnia and Metabolic Syndrome that has completed, run by University of Delaware. The registered enrollment target is 24 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05956886, a NA study of Insomnia and Metabolic Syndrome, has completed, sponsored by University of Delaware.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Unhealthy sleep and cardiometabolic risk are two major public health concerns in emerging Black/African American (BAA) adults. Evidence-based sleep interventions such as cognitive-behavioral therapy for insomnia (CBT-I) are available but not aligned with the needs of this at-risk group. Innovative work on the development of an artificial intelligence sleep chatbot using CBT-I guidelines will provide scalable and efficient sleep interventions for emerging BAA adults.
Primary Outcome
Results were report as # of participants reporting Acceptable and Completely acceptable. Acceptability question: "Overall, how acceptable was the sleep chat bot intervention to you? (Completely unacceptable; Unacceptable; No opinion; Acceptable; Completely acceptable)."
Conditions Studied
Interventions
- BEHAVIORAL sleep chatbot
Study Locations (1)
Delaware
- University of Delaware - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2023-09-04 |
| Est. Completion | 2025-02-05 |
| Phase | NA |
What the finished NCT05956886 record still lists
NCT05956886 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (86% lower).
The record links to 3 conditions, with Insomnia appearing as the primary indexed condition, and to 1 intervention - of which sleep chatbot is the first listed.
NCT05956886 reports a single indexed study location in Delaware.
Frequently Asked Questions
What is clinical trial NCT05956886 about?
NCT05956886 is a clinical study titled "Sleep Chatbot Intervention for Emerging Black/African American Adults". Unhealthy sleep and cardiometabolic risk are two major public health concerns in emerging Black/African American (BAA) adults. Evidence-based sleep interventions such as cognitive-behavioral therapy for insomnia (CBT-I) are available but not aligned with the needs of this at-risk group. Innovative w...
What is the current status of trial NCT05956886?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2023-09-04. Estimated completion is 2025-02-05.
What conditions does trial NCT05956886 study?
This clinical trial studies the following conditions: Insomnia, Metabolic Syndrome, Sleep Deprivation.
What interventions are being tested in trial NCT05956886?
The interventions under investigation include: sleep chatbot (BEHAVIORAL).
Who is sponsoring clinical trial NCT05956886?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05956886 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05956886's enrollment target sits among peer trials
24 132nd of 151 higher than 20 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
RECRUITING · NA
-
Treatments in Women Veterans With Insomnia and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI